I

Inventiva
IVA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€302.29M
EV
€386.63M
Shares Outstanding
95.67M
Beta
0.99

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€6.30
P/E 2025E
-
P/Revenue 2025E
20.73x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Inventiva S.A.

gainify

I

Inventiva S.A.

IVA

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clin...

Sector

Healthcare

Industry

Biotechnology

CEO

Cren, Frederic

Employees

116

IPO Date

2017-02-15

Headquarters

50 rue de Dijon, Daix, Burgundy, 21121, France

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved